Clinical trial

Reducing Innate Inflammation in New Onset Type 1 Diabetes

NCT04335656

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2021-04-01

PhasePHASE2

Study timeline

Study start (actual)2021-04-01Date precision: day

Registry last updated2026-03-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetesunresolved

type1diabetesunresolved

Type 1 Diabetes Mellitusunresolved

Interventions

Lactiplantibacillus plantarumDIETARY_SUPPLEMENT

PlaceboOTHER

Sponsors & collaborators

Medical College of Wisconsinlead sponsor

Mapped research locations

MilwaukeeWisconsin, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04335656 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.